Cargando…
Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disease representing the most common type of dementia worldwide. The early diagnosis of AD is very difficult to achieve due to its complexity and the practically unknown etiology. Therefore, this is one of the greatest challenges in the field in order...
Autores principales: | Custodia, Antía, Ouro, Alberto, Romaus-Sanjurjo, Daniel, Pías-Peleteiro, Juan Manuel, de Vries, Helga E., Castillo, José, Sobrino, Tomás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825416/ https://www.ncbi.nlm.nih.gov/pubmed/35153724 http://dx.doi.org/10.3389/fnagi.2021.811210 |
Ejemplares similares
-
CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022) -
Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke
por: Custodia, Antía, et al.
Publicado: (2022) -
Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
por: Custodia, Antía, et al.
Publicado: (2023) -
Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population
por: Vázquez-Reza, María, et al.
Publicado: (2023) -
Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Custodia, Antía, et al.
Publicado: (2022)